Urinary incontinence: Pathophysiology and management outline

Australian Family Physician

Volumn 37, Issue 3, 2008, Pages 106-110

  Santiagu, Stanley K ^a   Arianayagam, Mohan ^a   Wang, Audrey ^a   Rashid, Prem ^b  

^a PORT MACQUARIE BASE HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUSTRALIA; FEMALE; HUMAN; INCIDENCE; PATHOPHYSIOLOGY; PRIMARY HEALTH CARE; QUALITY OF LIFE; REVIEW; RISK FACTOR; URINE INCONTINENCE;

AUSTRALIA; FEMALE; HUMANS; INCIDENCE; PRIMARY HEALTH CARE; QUALITY OF LIFE; RISK FACTORS; URINARY INCONTINENCE;

EID: 42449143910     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. Am J Obstet Gynecol 2002;187:116-26.
2. Continence Foundation of Australia. Available at www.continence.org.au.
3. Holst K, Wilson PD. The prevalence of female urinary incontinence and reasons for not seeking treatment. N Z Med J 1988;101:756-8.
4. O'Donnell M, Viktrup L, Hunskaar S. The role of general practitioners in the initial management of women with urinary incontinence in France, Germany, Spain and the UK. Eur J Gen Pract 2007;13:20-6.
5. Morrison A, Levy R. Fraction of nursing home admissions attributable to urinary incontinence. Value in Health 2006;9:272-4.
6. Brading AF. A myogenic basis for the overactive bladder. Urology 1997;50(6A Suppl):57-67; discussion 8-73.
7. de Groat WC. A neurologic basis for the overactive bladder. Urology 1997;50(6A Suppl):36-52; discussion 3-6.
8. van der Vaart CH, de Leeuw JR, Roovers JP, Heintz AP. The effect of urinary incontinence and overactive bladder symptoms on quality of life in young women. BJU Int 2002;90:544-9.
9. Coyne KS, Zhou Z, Thompson C, Versi E. The impact on health-related quality of life of stress, urge and mixed urinary incontinence. BJU Int 2003;92:731-5
10. Artibani W, Cerruto MA. The role of imaging in urinary incontinence. BJU Int 2005;95:699-703.
11. Homma Y. The clinical significance of the urodynamic investigation in incontinence. BJU Int 2002;90:489-97.
12. Subak LL, Whitcomb E, Shen H, Saxton J, Vittinghoff E, Brown JS. Weight loss: a novel and effective treatment for urinary incontinence. J Urol 2005;174:190-5.
13. Bo K, Borgen JS. Prevalence of stress and urge urinary incontinence in elite athletes and controls. Med Sci Sports Exerc 2001;33:1797-802.
14. Swithinbank L, Hashim H, Abrams P. The effect of fluid intake on urinary symptoms in women. J Urol 2005;174:187-9.
15. Bump RC, McClish DM. Cigarette smoking and pure genuine stress incontinence of urine: a comparison of risk factors and determinants between smokers and nonsmokers. Am J Obstet Gynecol 1994;170:579-82.
16. Hannestad YS, Rortveit G, Daltveit AK, Hunskaar S. Are smoking and other lifestyle factors associated with female urinary incontinence? The Norwegian EPINCONT Study. BJOG 2003;110:247-54.
17. Hay-Smith EJ, Bo Berghmans LC, Hendriks HJ, de Bie RA, van Waalwijk van Doorn ES. Pelvic floor muscle training for urinary incontinence in women. Cochrane Database Syst Rev 2001;(1):CD001407.
18. Aksac B, Aki S, Karan A, Yalcin O, Isikoglu M, Eskiyurt N. Biofeedback and pelvic floor exercises for the rehabilitation of urinary stress incontinence. Gynecol Obstet Invest 2003;56:23-7.
19. Wallace SA, Roe B, Williams K, Palmer M. Bladder training for urinary incontinence in adults. Update of Cochrane Database Syst Rev. 2000;(2):CD001308; Cochrane Database Syst Rev 2004;(1):CD001308.
20. Wilson P. Incontinence. Plymbridge Distributors; 1999, p. 579-634.
21. Nabi G, Cody JD, Ellis G, Herbison P, Hay-Smith J. Anticholinergic drugs versus placebo for overactive bladder syndrome in adults. Cochrane Database Syst Rev 2006; Issue 4. Art. No.: CD003781.
22. Alhasso AA, McKinlay J, Patrick K, Stewart L. Anticholinergic drugs versus non-drug active therapies for overactive bladder syndrome in adults. Cochrane Database Syst Rev 2006; Issue 4. Art. No.: CD003193.
23. Hashim H, Abrams P. Pharmacological management of women with mixed urinary incontinence. Drugs 2006;66:591-606.
24. Mariappan P, Alhasso A, Ballantyne Z, Grant A, N'Dow J. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review. Eur Urol 2007;51:67-74.
25. Grady D, Brown JS, Vittinghoff E, et al. Postmenopausal hormones and incontinence: the Heart and Estrogen/Progestin Replacement Study. Obstet Gynecol 2001;97:116-20.
26. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology 2003;61:37-49.